New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway

BURLINGTON, ON —A multi-center clinical study to evaluate the effectiveness and safety of taking Lignisul MSM for the treatment of pain in osteoarthritis of the knee and hip is to be undertaken by the Carolwood Corporation. The effectiveness of Lignisul MSM will be directly compared to naproxen, the non-steroidal anti-inflammatory drug (NSAID) which is widely prescribed throughout the world. Although naproxen is now a generic drug because the patent has run out, it is still a costly treatment and newer drugs like Celebrex and Vioxx can be prohibitively expensive for those seeking pain relief.

Even though the majority of patients use NSAIDs for pain control, side effects such as dyspepsia, gastrointestinal bleeding, exacerbation of blood pressure and renal failure can limit their use. Therefore new treatments are actively sought. In addition, there is a very real trend among patients with rheumatological problems, to seek alternative therapies, which are thought to be safer and more natural, for pain relief.

The prime goal of this 12 month study is to enable patients and physicians to make informed decisions when considering the use of Lignisul MSM to alleviate the pain of osteoarthritis; the most common form of arthritis in patients over 40 years of age and it is commonly found in the knee and hip joints. It will have strict inclusion criteria including: disease duration, pain intensity, previous use of NSAIDs or analgesic therapies, and age. The ultimate aim will be to demonstrate the effectiveness of Lignisul MSM compared to naproxen, offering sufferers an alternative therapy that works, improving their physical function and quality of life.

Lignisul MSM is a nutritional supplement that provides biologically-active sulfur. It is manufactured by the Carolwood Corporation and is an all-natural, ultrapure MSM. Recent pilot studies of methyl-sulfonyl-methane (MSM), indicate that it may offer a safe, non-toxic way to help ease the pain of arthritis and other inflammatory conditions in humans. Considering that sulfur concentration in arthritic cartilage has been reported to be one-third the level in normal cartilage suggests that supplementation with MSM could lead to repletion of sulfur with beneficial effects.


Carolwood Corporation, Greenville PA
is the exclusive manufacturer and supplier of LignisulMSM,
an all-natural, patented nutritional supplement
that provides biologically-active sulfur
for arthritis, muscle and joint pain.

For more information, Call (888) 646-0350,
or check out our web site at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.